ASC41公布2期期中数据,具备同靶点best-in-class潜质
CMBI Research Focus List:Our best high conviction ideas
医药生物行业周报:Dato-DXd有望成为全球首个治疗肺癌的 TROP2 ADC,国产SKB 264有潜力成为Best in class
The Best of IMTS 2024
Best-in-Class Professional Services Management
Innovent Biologics (1801 HK) Mazdutide (IBI362) to become the best GLP-1 drug for obesity in China
Adaptation and implementation of WHO’s multisectoral accountability framework to end TB (MAF-TB): best practices
Best Practices for Developing a “Just Right” Budget Plan for Your Business
CMBI Research Focus List: Our best high conviction ideas
医药生物行业报告简版:创新药价值分析:First-in-Class、Best-in-Class哪个更重要?市场推广投入对市场份额影响有多大?